Abstract

BackgroundAs thousands of healthy research participants are being included in small and large imaging studies, it is essential that dilemmas raised by the detection of incidental findings are adequately handled. Current ethical guidance indicates that pathways for dealing with incidental findings should be in place, but does not specify what such pathways should look like. Building on an interview study of researchers’ practices and perspectives, we identified key considerations for the set-up of pathways for the detection, management and communication of incidental findings in imaging research.MethodsWe conducted an interview study with a purposive sample of researchers (n = 20) at research facilities across the Netherlands. Based on a qualitative analysis of these interviews and on existing guidelines found in the literature, we developed a prototype ethical framework, which was critically assessed and fine-tuned during a two-day international expert meeting with bioethicists and representatives from large population-based imaging studies from the United Kingdom, Germany, Sweden and Belgium (n = 14).ResultsPractices and policies for the handling of incidental findings vary strongly across the Netherlands, ranging from no review of research scans and limited feedback to research participants, to routine review of scans and the arrangement of clinical follow-up. Respondents felt that researchers do not have a duty to actively look for incidental findings, but they do have a duty to act on findings, when detected. The principle of reciprocity featured prominently in our interviews and expert meeting.ConclusionWe present an ethical framework that may guide researchers and research ethics committees in the design and/or evaluation of appropriate pathways for the handling of incidental findings in imaging studies. The framework consists of seven steps: anticipation of findings, information provision and informed consent, scan acquisition, review of scans, consultation on detected abnormalities, communication of the finding, and further clinical management and follow-up of the research participant. Each of these steps represents a key decision to be made by researchers, which should be justified not only with reference to costs and/or logistical considerations, but also with reference to researchers’ moral obligations and the principle of reciprocity.

Highlights

  • As thousands of healthy research participants are being included in small and large imaging studies, it is essential that dilemmas raised by the detection of incidental findings are adequately handled

  • Pathways and policies for the handling of incidental findings differ across the Netherlands Pathways and policies for the detection, management and communication of incidental findings were variable: some centres had detailed pathways in place, outlining what to do and whom to contact in case abnormalities were detected, while other centres were still in the process of setting up policies or pathways for the handling of incidental findings, or were struggling with incidental findings on a case-by-case basis

  • Internal documents described standard operating procedures researchers or radiographers were expected to follow when confronted with abnormalities. While these procedures were largely similar (e.g. scans should be saved in specific ways and on specific locations, a person centrally handling incidental findings should be contacted, the researcher should wait for a confirmatory response from aradiologist), there were differences with regard to whether or not researchers or radiographers were required to make additional diagnostic-quality scans of potentially abnormal brains, and whether or not they were allowed to inform the research participant about the finding during the scanning process

Read more

Summary

Introduction

As thousands of healthy research participants are being included in small and large imaging studies, it is essential that dilemmas raised by the detection of incidental findings are adequately handled. The prevalence of clinically significant incidental findings among healthy participants is estimated around 2.7% in brain MRI, with a number needed to scan of around 37 for one finding deemed of clinical significance [7]. In Europe, large populationbased cohort studies are currently underway, in which (tens of ) thousands of healthy research participants are undergoing imaging of the body or brain – in the case of UK Biobank, even a hundred thousand [10, 12,13,14,15,16]. Large numbers of incidental findings can be expected in the few years

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call